Vr Adviser, LLC Akouos, Inc. Transaction History

Vr Adviser, LLC

  • $1.17 Billion
  • Q1 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

May 15, 2023
BUY
$2.6 - $5.16 $346,962 - $688,586
133,447 Added 5.0%
2,800,566 $12.4 Million
Q3 2022

Nov 14, 2022
BUY
$2.6 - $5.16 $346,962 - $688,586
133,447 Added 5.0%
2,800,566 $18.9 Million
Q2 2022

May 15, 2023
BUY
$2.46 - $5.2 $6.56 Million - $13.9 Million
2,667,119 New
2,667,119 $12.5 Million
Q2 2022

Aug 15, 2022
BUY
$2.46 - $5.2 $6.56 Million - $13.9 Million
2,667,119 New
2,667,119 $12.5 Million

About Akouos, Inc.

AKUS Quotes by TradingView
  • Ticker AKUS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 36,929,000
  • Description
  • Akouos, Inc., a precision genetic medicine company, developing gene therapies to restore, improve, and preserve physiologic hearing for individuals. The company's precision genetic medicine platform incorporates a proprietary adeno-associated viral vector library and a novel delivery approach. Its lead product candidate is AK-OTOF, a gene therap...
More about AKUS
Track This Portfolio

Track Vr Adviser, LLC Portfolio

Follow Vr Adviser, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vr Adviser, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vr Adviser, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email